Acurx Pharmaceuticals Ownership
| ACXP Stock | USD 0.43 0.01 2.38% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 16.4 M | Current Value 16.3 M | Avarage Shares Outstanding 11.5 M | Quarterly Volatility 2.8 M |
Acurx |
Acurx Stock Ownership Analysis
The company recorded a loss per share of 0.87. Acurx Pharmaceuticals LLC had not issued any dividends in recent years. Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. For more info on Acurx Pharmaceuticals LLC please contact the company at 917 533 1469 or go to https://www.acurxpharma.com.Besides selling stocks to institutional investors, Acurx Pharmaceuticals also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Acurx Pharmaceuticals' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Acurx Pharmaceuticals' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Acurx Pharmaceuticals Quarterly Liabilities And Stockholders Equity |
|
About 12.0% of Acurx Pharmaceuticals LLC are currently held by insiders. Unlike Acurx Pharmaceuticals' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Acurx Pharmaceuticals' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Acurx Pharmaceuticals' insider trades
Acurx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Acurx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acurx Pharmaceuticals LLC backward and forwards among themselves. Acurx Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Acurx Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-12-31 | 14.7 K | Advisor Group Holdings, Inc. | 2024-12-31 | 14.2 K | Squarepoint Ops Llc | 2024-12-31 | 12.5 K | Patriot Financial Group Insurance Agency, Llc | 2024-12-31 | 10.4 K | Ubs Group Ag | 2024-12-31 | 6 K | Semmax Financial Advisors Inc. | 2024-09-30 | 5.9 K | Tower Research Capital Llc | 2024-12-31 | 4.4 K | Cornerstone Planning Group Llc | 2024-12-31 | 3.3 K | Northwestern Mutual Wealth Management Co | 2024-12-31 | 1.6 K | Vanguard Group Inc | 2024-12-31 | 529.3 K | Prospect Financial Services Llc | 2024-12-31 | 329.1 K |
Acurx Pharmaceuticals LLC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acurx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acurx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acurx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Acurx Pharmaceuticals Outstanding Bonds
Acurx Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Acurx Pharmaceuticals LLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Acurx bonds can be classified according to their maturity, which is the date when Acurx Pharmaceuticals LLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ACURIS FIN 5 Corp BondUS00511BAA52 | View | |
| US00510RAD52 Corp BondUS00510RAD52 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Pair Trading with Acurx Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acurx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Acurx Stock
Moving against Acurx Stock
| 0.66 | LUCD | Lucid Diagnostics | PairCorr |
| 0.6 | WM | Waste Management | PairCorr |
| 0.45 | GE | GE Aerospace | PairCorr |
| 0.38 | PG | Procter Gamble | PairCorr |
The ability to find closely correlated positions to Acurx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acurx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acurx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acurx Pharmaceuticals LLC to buy it.
The correlation of Acurx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acurx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acurx Pharmaceuticals LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acurx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.